Professional Marketing briefs: February 2014

Share this article:
Professional Marketing briefs: February 2014
Professional Marketing briefs: February 2014

The Department of Justice has taken an interest in Aegerion Pharmaceuticals, which makes Juxtapid. Aegerion said the government agency has asked for documents surrounding the medication. The ­company got some negative attention in November for comments that its CEO made about Juxtapid on television, but Aegerion says it does not think those comments prompted the DOJ's subpoena.

Obesity drug maker Vivus has secured a marketing-friendly position: preferred brand or non-preferred brand on the Caremark formulary, which will mean co-payments of between $15 and $75 for insured patients whose coverage includes obesity drugs.

Merck is laying off Saphris sales reps. Philly.com reports that the drugmaker will shed the sales force as of February. The layoffs are part of an overhaul that included laying off 8,500 employees and selling Saphris to Forest Laboratories in December.

Gilead's EVP of commercial operations, Kevin Young, has announced his retirement, effective Feb. 4, the biotech firm said. Young's move came just as Gilead is set to launch the HCV treatment Solvadi, which the FDA approved in December.

Share this article:
You must be a registered member of MMM to post a comment.

Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric